Our results show that metformin, sulfonylureas, and insulin are all associated with a reduction in the hazard of cardiovascular mortality and HF hospitalization, with no antidiabetic medication class having a clear association with greater benefit. The gene discussed is INS; the disease is hydrops fetalis.